The NYU Cancer Institute, located at 160 E 34th St.specializes in clinical trials including gene therapy, new congeners of DNA topoisometase inhibitors, and research in angiogenesis, transgenic mouse models, uroepithelial cancer, breast cancer, and lung cancer.